TSX:TH (Theratechnologies)
About TH
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
Theratechnologies (TSX: TH) Latest News

Investing
2 Biotech Stocks to Buy Before the Down Market Recovers

Page
Top Biotech Stocks in Canada of 2023

Investing
Value Stocks: 1 Cheap Healthcare Company for TFSA Investors

Investing
Healthcare Stocks Are up an Insane 37.9% in 2021

Investing
1 Small-Cap Biotech Stock for High-Risk Canadian Investors

Investing
2 TSX 30 Growth Stocks With Returns That Will Make Your Jaw Drop

Tech Stocks
The Best Canadian Stock to Buy Right Now!

Investing
3 High-Growth Stocks That Can Boost Your TFSA to New Heights

Dividend Stocks
4 Stocks That Are Absurdly Cheap Right Now

Dividend Stocks
Forget Big Oil Stocks: 1 Aggressive Strategy for Young Investors

Investing
3 Reasons This Biotech Stock Could Double in 2019

Energy Stocks
Are These the Safest 4 Stocks for a High-Growth Strategy?
1❯